What is a stock summary page? Click here for an overview.
Business Description
DexTech Medical AB
ISIN : SE0005881489
Compare
Compare
Traded in other countries / regions
DEX.SwedenLQ0.Germany IPO Date
2014-06-19Description
DexTech Medical AB develops candidate medications with applications within urological oncology, for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases. The company has a well built clinical base with valuable specialist expertise from research laboratories and manufacturing to clinical oncology.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.99 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 9.1 | |||||
| 3-Year EPS without NRI Growth Rate | 15.2 | |||||
| 3-Year FCF Growth Rate | -22.7 | |||||
| 3-Year Book Growth Rate | 51.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.75 | |||||
| 9-Day RSI | 52.79 | |||||
| 14-Day RSI | 50.24 | |||||
| 3-1 Month Momentum % | 5.47 | |||||
| 6-1 Month Momentum % | -4.93 | |||||
| 12-1 Month Momentum % | -29.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 79.08 | |||||
| Quick Ratio | 79.08 | |||||
| Cash Ratio | 77.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -16.16 | |||||
| ROA % | -15.79 | |||||
| ROIC % | -52.57 | |||||
| 3-Year ROIIC % | 6.68 | |||||
| ROC (Joel Greenblatt) % | -3714.38 | |||||
| ROCE % | -19.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.59 | |||||
| Price-to-Tangible-Book | 4.47 | |||||
| EV-to-EBIT | -9.64 | |||||
| EV-to-EBITDA | -11.82 | |||||
| EV-to-FCF | -61.2 | |||||
| Price-to-Projected-FCF | 11.06 | |||||
| Price-to-Net-Current-Asset-Value | 4.47 | |||||
| Price-to-Net-Cash | 4.57 | |||||
| Earnings Yield (Greenblatt) % | -10.38 | |||||
| FCF Yield % | -1.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DexTech Medical AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.26 | ||
| Beta | 3.08 | ||
| 3-Year Sharpe Ratio | -0.22 | ||
| 3-Year Sortino Ratio | -0.42 | ||
| Volatility % | 29.79 | ||
| 14-Day RSI | 50.24 | ||
| 14-Day ATR (kr) | 0.136142 | ||
| 20-Day SMA (kr) | 3.957 | ||
| 12-1 Month Momentum % | -29.33 | ||
| 52-Week Range (kr) | 3.54 - 6.35 | ||
| Shares Outstanding (Mil) | 18.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DexTech Medical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DexTech Medical AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
DexTech Medical AB Frequently Asked Questions
What is DexTech Medical AB(XSAT:DEX)'s stock price today?
The current price of XSAT:DEX is kr3.98. The 52 week high of XSAT:DEX is kr6.35 and 52 week low is kr3.54.
When is next earnings date of DexTech Medical AB(XSAT:DEX)?
The next earnings date of DexTech Medical AB(XSAT:DEX) is 2025-04-29.
Does DexTech Medical AB(XSAT:DEX) pay dividends? If so, how much?
DexTech Medical AB(XSAT:DEX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers